PSAILA LAB

Beth is a Group Leader at the MRC Weatherall Institute of Molecular Medicine and a haematology consultant specialising in the care of patients with myeloproliferative neoplasms. Before Oxford, she trained at Clare College, Cambridge University, University College London Hospitals and The Hammersmith Hospital/Imperial College London and also spent >6 years in the US at Cornell University, New York and the National Human Genome Research Institute, National Institutes of Health, Bethesda. She has been studying megakaryocytes/platelets and haematopoiesis for >15 years, leading to a strong national and international research network. She is passionate about translational science, motivated to apply state-of-the-art techniques to better understand mechanisms of disease in her patients, identify new therapeutic strategies and develop more clinically relevant models for target validation.  She enjoys mentoring, and alumni from her group have an excellent track record in securing personal fellowships, independent grant funding and positions in industry. Together with Adam Mead, she is a co-founder of Alethiomics, a recent spin-out company from the WIMM. 

​

Outside of work, she enjoys adventures with her husband and three children, and escaping for runs around beautiful Oxford with her over-enthusiastic but surprisingly obedient cockapoo.